Sopharma AD
Sopharma AD
08/20/2026 | Press release | Distributed by Public on 08/20/2026 05:07
Updated preliminary sales revenue data for July 2026
Sofia, Bulgaria, August 20, 2026 - "Sopharma" AD (SFA: "Bulgarian Stock Exchange" AD, SPH: Warsaw Stock Exchange) pursuant to the requirements of art. 100t of the Law on Public Offering of Securities (LPOS), hereby informs that in July 2026 the Company reported a 103% increase in sales compared to the same month of the previous year, including a 31% increase in domestic sales and a 151% increase in export sales.
For the period from the beginning of 2026 through the end of July, the Company reported a 52% increase in sales compared to the same period of the previous year, including a 2% increase in domestic sales and an 82% increase in export sales.
Sopharma AD published this content on August 20, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 20, 2026 at 11:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]